Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun 8;76(11):2039-2041.
doi: 10.1093/cid/ciad133.

Reply to Gonzales-Luna et al

Amy S Gargis  1 , Maria Karlsson  1   2 , J Kamile Rasheed  1 , Alyssa G Kent  1 , Susannah L McKay  1 , Ashley L Paulick  1 , Karen F Anderson  1 , Michelle Adamczyk  1 , Davina Campbell  1 , Lauren C Korhonen  1 , Gillian McAllister  1 , Nicholas Vlachos  1 , Alison L Halpin  1 , Joseph D Lutgring  1 , Alice Y Guh  1 , L Clifford McDonald  1 , Christopher A Elkins  1
Affiliations

Reply to Gonzales-Luna et al

Amy S Gargis et al. Clin Infect Dis. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Potential conflicts of interest. L. C. M. reports participation on a data safety monitoring board or advisory board for the Division of Microbiology and Infectious Disease, National Institutes of Health (protocol 19-0021: A Randomized, Double-blinded Evaluation of CRS3123 in Patients with Non-severe to Severe Clostridium difficile Infection). All other authors report no potential conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed.

Comment on

References

    1. Gonzales-Luna A, Dureja C, Eubank TA, Garey KW, Hurdle JG. Surveillance of Clostridioides difficile antimicrobial resistance in the United States. Clin Infect Dis 2023; 76:2038–9. - PMC - PubMed
    1. Clinical and Laboratory Standards Institute. Methods for antimicrobial susceptibility testing of anaerobic bacteria. 9th ed. CLSI M11. Wayne, PA: Clinical and Laboratory Standards Institute, 2018.
    1. Gargis AS, Karlsson M, Paulick AL, et al. Reference susceptibility testing and genomic surveillance of Clostridioides difficile, United States, 2012–17. Clin Infect Dis 2023; 76:890–6. - PMC - PubMed
    1. Wu X, Shen WJ, Deshpande A, et al. The integrity of heme is essential for reproducible detection of metronidazole-resistant Clostridioides difficile by agar dilution susceptibility tests. J Clin Microbiol 2021; 59:e0058521. - PMC - PubMed
    1. Olaitan AO, Dureja C, Youngblom MA, et al. Decoding a cryptic mechanism of metronidazole resistance among globally disseminated fluoroquinolone-resistant Clostridioides difficile. bioRxiv [Preprint]. September 26, 2022. Available from: https://www.biorxiv.org/content/10.1101/2022.09.23.509282v2. - DOI - PMC - PubMed

LinkOut - more resources